Clinical trial
ADRB3 Signaling Pathway in Human Adipose Tissue
NCT05634174
Study timeline
Study start (actual)2023-08-01Date precision: day
Registry last updated2024-10-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Obesity, Prediabetesunresolved
Interventions
MirabegronDRUG · verified · RxNorm: mirabegron
Sponsors & collaborators
University of California, San Diegolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05634174 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.